Clinical Trial Update: Systolic Hypertension in Europe Placebo-Controlled Trial [Phase 2]

View source ↗

Summary

Phase 2 placebo-controlled trial for isolated systolic hypertension in Europe has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Isolated Systolic Hypertension

Snippet

Sponsor: KU Leuven | Conditions: Isolated Systolic Hypertension | Phase 2 | Status: TERMINATED